Navigation Links
Gardasil Could Be Effective, but Aggressive Marketing Raises Ethical Concerns

Mercks Gardasil does show real promise for reducing HPV infection in women. Given the increasingly permissive ways of the West , the human papilloma virus is a looming danger and one has to go all out to fight cervical cancer.

But the multi-million marketing by the multi-national drug manufacturer has made experts uneasy.

To give the impression that it could completely eliminate cervical cancer is quite misleading, they say.

Merck used their deep pockets to make sure that even before the FDA had approved Gardasil, The marketing juggernaut was multifaceted and meticulously planned. In 2005 Merck started by funding a campaign called "Make the Connection," run by avowed non-governmental organizations.

A key element of the campaign is the Make the Connection bead, part of a create-it-yourself bracelet kit that will help raise cervical cancer awareness. Make the Connection bracelet kits are available free through the campaign's Web site and toll-free information line -www.maketheconnection.org and 888-4-HPV-CONNECT -and also at Make the Connection beading events across the country. Everyone who orders the free Make the Connection bracelet kit will get two kits, so she can invite someone to join her in showing support against cervical cancer. The beading events will bring women together to bead, talk about cervical cancer and meet the young actresses who are part of the campaign:, so gushed a website.

It is estimated that 563 million people were reached by the TV spots and print coverage in Elle, Redbook, Self, People, Women's Health and many more popular magazines.

"Make the Connection" was eventually transformed into "Make the Commitment." Funded by Merck, "Make the Commitment" nudged women along the path of demanding Gardasil when it would be FDA approved and available.

At the "Make the Commitment" website, women are challenged to sign the following pledge:

"I, (your name), am mak
'"/>
SOURCE The Politics and PR of Cervical Cancer



Page: 1 2 3 4 5

Related medicine news :

1. Gardasil vaccine for cervical cancer
2. Gardasil- Cervical Cancer Vaccine Now Approved
3. Gardasil, a cervical cancer vaccine, hits the market
4. Gardasil Hailed as one of the Biggest Research Successes
5. Cervical Cancer Vaccine Gardasil Included In Subsidized CDC program
6. Gardasil Refused Subsidy
7. School Vaccination Program to Include Cancer Drug Gardasil
8. Developing Nations to Get Gardasil at Lesser Rates from Merck Soon
9. Gardasil – Cervical Cancer Vaccine in UA
10. Acid Test - Glaxos Cervarix, and Mercks Gardasil, Compete
11. Gardasil Effective in Preventing Vaginal, Vulvar Cancers, Study Finds

Post Your Comments:
(Date:11/25/2009)...BroadPoliticalEndorsements,Business,andPressJoinEf...re-USNewswire/--Onceagain,theNationalBipolarFounda...endorsingtheir"Safe,tilStable"program,whichisnowbe...bipolardisorder.Today,theNationalBipolarFoundation...sPriorityMailfromtheLt.GovernorofLouisianaMitchLan...
(Date:11/25/2009)...tuitous discovery that grew out of a collaboration...tially offer hope to the nearly 10 million America... , Also known as hardening of the arteries, per...ulatory problem in which narrowed arteries reduce ...ed a red flag for vascular disease, heart attack a...
(Date:11/25/2009)..., already used to fight rheumatoid arthritis, coul... , WEDNESDAY, Nov. 25 (HealthDay News) -- A...a and rheumatoid arthritis now also shows some pro... 1 diabetes. , The drug, rituximab (Rituxan), h...sulin, even though the disease had destroyed some ...
(Date:11/25/2009)... often plagued by neurological symptoms, study fin...ws) -- Neurological side effects are among the pot...sticular cancer who were treated with cisplatin-ba...study included 1,409 Norwegian men treated for uni...o took part in a follow-up survey conducted from 1...
(Date:11/25/2009)...RLINGTON,Va.,Nov.25/PRNewswire-USNewswire/--TheAme...ealthCareFraudActof2009,"S.2128,whichisdesignedtos...ventfraudinMedicare.ThebillwasintroducedbySen.Geor...eralprovisionstheAmericanAssociationforHomecareout...ociationproposedtoCongressinFebruary.Thoseprovisio...
Breaking Medicine News(10 mins):Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2
...itute for Biological Studies during embryonic deve...produce// tentacle-like protrusions. These are cal...r destination. They guide the nerve cells through ...in the limb, scientists at the Salk Institute for ...
...s on obesity finalized to cause harm to children, .... Due to financial agreements made between t...ing this proposal, an unfit guideline was being ma...rican Medical Association has ‘tentatively decided...
...n makes women more disabled than men – study publi...s treatment procedures targeting to reduce stress ...reduce disability. This suggests that by targe... which involved 260 chronic pain patients from Roy...
...act fast when their reputation is at stake. Now th...nd credibility by doing something solid about all ...hicken, Wendy's, McDonald's and Burger King are al...nt. Jeff O'Neill, president and chief operat...
...omen, women overweight in their teens or later are...r. // This research was conducted by scientists at...The participants of the study were some 2,110 wome... were more likely to develop the disease compared ...
... portion of the horses in the Meath/Kildare region...g to reports from The Department of Agriculture an...ne Infectious Anemia, has an incubation period of ...s are being conducted to ascertain the facts. Ther...
Other Medicine News:Health News:Growth Factors Help Neurons to Reach Their Correct Destination 2Health News:Growth Factors Help Neurons to Reach Their Correct Destination 3Health News:New Obesity Guidelines Will Trouble US Children 2Health News:Depression And Chronic Pain Cause Disability In Women 2
(Date:11/25/2009)...rstCall/--Pharmasset,Inc.(Nasdaq: VRUS ),aclinical...evelopingandcommercializingnoveldrugstotreatvirali...endedSeptember30,2009.AtSeptember30,2009Pharmasset...investments. ,, PipelineUpdateand2009Highlight...ateNovember2009,anindependentDataMonitoringCommitt...
(Date:11/25/2009)...PRNewswire/-- FromNovember16-18,Phonak,theleadingm...hesecondeditionoftheHearingCareforAdultsConference...conferencebroughttogetherleadingexpertsinaginganda...whoworkeverydaywitholderpeoplewithhearinglossforan...searchandtrendsinhearingcareforolderpeople. ,,...
(Date:11/25/2009)...--TheFDAgrantedtraditionalapprovalforINTELENCE...riptaseinhibitor(NNRTI).INTELENCEistheonlyNNRTIspe...ltswhoareexperiencingvirologicfailurewithHIV-1stra...ents.Thetraditionalapprovalisbasedon48-weekdatafro...scurrentlymarketedintheU.S.byTibotecTherapeutics,a...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection 28CDI 29 5005 1Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection 28CDI 29 5005 2Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection 28CDI 29 5005 3Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection 28CDI 29 5005 4Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection 28CDI 29 5005 5Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection 28CDI 29 5005 6The Celebrate Wellness Expo Presents Motivational Speaker 26 Author Dr Robin L Smith and Spiritual Teacher 26 Author Rev Michael Bernard Beckwith 57249 1The Celebrate Wellness Expo Presents Motivational Speaker 26 Author Dr Robin L Smith and Spiritual Teacher 26 Author Rev Michael Bernard Beckwith 57249 2ATS Medical to Participate at the 2009 UBS Global Life Sciences Conference 57246 1ATS Medical to Participate at the 2009 UBS Global Life Sciences Conference 57246 2
... Therapeutics, Inc. (Nasdaq: TPTX ) today announ...ial evaluating three doses of NGX267 as a treatmen...jogren,s syndrome. NGX267 met the primary endpoin...ary flow production compared to placebo at all thr...e safe and well tolerated with few reports of exce...
... (Nasdaq: MITI ), a biopharmaceutical company de...atment of cancer, inflammation and autoimmune dise...agreement expanding its Committed Equity Financing... a private investment group. Under the terms of t... up to $75 million of capital during the next thre...
Other Medicine Technology:TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 2TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 3TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 4TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 5Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6
...ears -- and works! Baby Gender Mentor Home DNA Gen...nology to attain the earliest gender detection wit...cy. The technique traces the amount of Y chromosom...Here's how it works: Your baby releases its DNA in...
...roducts, ,Westmed designs, manufacturers and mark... and Respiratory professionals. Our mission is to ...linician's ability to deliver quality medical care..., ,Our web site is designed with our customers in...
...mbrane glycoprotein associated with tyrosine kinas...ancer show an amplification and/or over-expression...on of Herceptin® as a targeted therapy for bre...reast carcinoma has become very important in patie...
...roducts, ,Westmed designs, manufacturers and mark... and Respiratory professionals. Our mission is to ...linician's ability to deliver quality medical care..., ,Our web site is designed with our customers in...
Medicine Products: